MAPK3 and fragile X syndrome: To evaluate if BAER-101 corrects molecular defects, such as altered cellular signaling, in the FXS mouse model, we used phospho-ERK1/2- and ERK1/2-specific ELISAs to quantify ERK1/2 phosphorylation in hippocampal lysates from the mice after they underwent the behavioral testing.